Related Experiment Video
Updated: Aug 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[Panuveitis following intravesical bacille Calmette-Guerin therapy]
M Jacob1, J Gambrelle, J Fleury
1Service d'Ophtalmologie, Hôpital de la Croix-Rousse, Lyon.
Abstract:
Uveitis occurring after bacille Calmette-Guerin (BCG) intravesical therapy for bladder carcinoma is rare: only nine cases have been described. In two previous reports, vitreous cultures proved Mycobacterium bovis presence. We describe the case of an 85-year-old woman who presented with bilateral panuveitis 2 months after the last BCG intravesical instillation, with no other systemic symptom. There was no evidence for any other etiology for this uveitis. She was given oral antibiotics that were effective against Mycobacterium species, oral steroids, and anti-inflammatory drops. Her ophthalmologic status dramatically improved. This case highlights that these patients may have a good visual outcome, as long as diagnosis and treatment are not delayed.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi VI: Surgical Management
Acute Pyelonephritis I: Introduction
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
